Equillium Historical Financial Ratios

EQ Stock  USD 0.77  0.03  3.75%   
Equillium is recently reporting on over 96 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 1.05 will help investors to properly organize and evaluate Equillium financial condition quickly.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Equillium. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.

About Equillium Financial Ratios Analysis

EquilliumFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Equillium investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Equillium financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Equillium history.

Equillium Financial Ratios Chart

At this time, Equillium's PTB Ratio is relatively stable compared to the past year. As of 03/22/2025, PB Ratio is likely to grow to 1.05, while Operating Cash Flow Per Share is likely to drop (0.76).
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Equillium stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Equillium sales, a figure that is much harder to manipulate than other Equillium multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.
Most ratios from Equillium's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Equillium current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Equillium. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.At this time, Equillium's PTB Ratio is relatively stable compared to the past year. As of 03/22/2025, PB Ratio is likely to grow to 1.05, while Operating Cash Flow Per Share is likely to drop (0.76).
 2023 2024 2025 (projected)
Interest Debt Per Share0.03790.04350.0414
Revenue Per Share1.040.940.6

Equillium fundamentals Correlations

-0.48-0.590.080.930.280.730.58-0.48-1.00.280.26-0.15-0.321.00.08-0.490.21-0.18-0.490.49-0.890.29-0.49-0.49-0.18
-0.480.290.71-0.72-0.86-0.35-0.981.00.48-0.86-0.51-0.670.74-0.480.751.0-0.7-0.271.0-1.00.71-0.821.01.0-0.28
-0.590.29-0.04-0.63-0.21-0.85-0.360.290.61-0.21-0.20.080.15-0.61-0.030.3-0.160.10.3-0.30.5-0.190.30.30.08
0.080.71-0.04-0.12-0.710.06-0.590.71-0.08-0.710.0-0.520.350.080.990.7-0.32-0.090.7-0.680.25-0.410.70.690.01
0.93-0.72-0.63-0.120.560.720.8-0.72-0.930.560.410.14-0.540.93-0.15-0.730.51-0.05-0.730.73-0.950.53-0.72-0.730.0
0.28-0.86-0.21-0.710.560.240.83-0.86-0.281.00.160.49-0.650.28-0.74-0.860.72-0.05-0.860.86-0.660.52-0.86-0.860.01
0.73-0.35-0.850.060.720.240.43-0.35-0.740.240.23-0.1-0.160.740.05-0.360.18-0.13-0.360.36-0.640.23-0.36-0.36-0.11
0.58-0.98-0.36-0.590.80.830.43-0.98-0.580.830.550.62-0.790.58-0.63-0.990.710.24-0.990.99-0.770.82-0.99-0.990.29
-0.481.00.290.71-0.72-0.86-0.35-0.980.48-0.86-0.51-0.670.74-0.480.751.0-0.7-0.271.0-1.00.71-0.821.01.0-0.28
-1.00.480.61-0.08-0.93-0.28-0.74-0.580.48-0.28-0.260.150.32-1.0-0.080.49-0.210.180.49-0.490.89-0.290.490.490.18
0.28-0.86-0.21-0.710.561.00.240.83-0.86-0.280.160.49-0.650.28-0.74-0.860.72-0.05-0.860.86-0.660.52-0.86-0.860.02
0.26-0.51-0.20.00.410.160.230.55-0.51-0.260.160.77-0.510.26-0.11-0.520.590.86-0.520.53-0.150.9-0.52-0.530.9
-0.15-0.670.08-0.520.140.49-0.10.62-0.670.150.490.77-0.57-0.15-0.62-0.670.680.82-0.670.670.00.9-0.67-0.670.83
-0.320.740.150.35-0.54-0.65-0.16-0.790.740.32-0.65-0.51-0.57-0.320.40.74-0.53-0.230.74-0.750.5-0.680.740.74-0.38
1.0-0.48-0.610.080.930.280.740.58-0.48-1.00.280.26-0.15-0.320.08-0.490.21-0.18-0.490.49-0.890.29-0.49-0.49-0.18
0.080.75-0.030.99-0.15-0.740.05-0.630.75-0.08-0.74-0.11-0.620.40.080.74-0.4-0.190.74-0.730.25-0.50.740.73-0.1
-0.491.00.30.7-0.73-0.86-0.36-0.991.00.49-0.86-0.52-0.670.74-0.490.74-0.71-0.271.0-1.00.71-0.821.01.0-0.29
0.21-0.7-0.16-0.320.510.720.180.71-0.7-0.210.720.590.68-0.530.21-0.4-0.710.35-0.710.71-0.420.72-0.71-0.710.5
-0.18-0.270.1-0.09-0.05-0.05-0.130.24-0.270.18-0.050.860.82-0.23-0.18-0.19-0.270.35-0.270.280.290.75-0.28-0.280.95
-0.491.00.30.7-0.73-0.86-0.36-0.991.00.49-0.86-0.52-0.670.74-0.490.741.0-0.71-0.27-1.00.71-0.821.01.0-0.29
0.49-1.0-0.3-0.680.730.860.360.99-1.0-0.490.860.530.67-0.750.49-0.73-1.00.710.28-1.0-0.720.82-1.0-1.00.3
-0.890.710.50.25-0.95-0.66-0.64-0.770.710.89-0.66-0.150.00.5-0.890.250.71-0.420.290.71-0.72-0.350.710.710.25
0.29-0.82-0.19-0.410.530.520.230.82-0.82-0.290.520.90.9-0.680.29-0.5-0.820.720.75-0.820.82-0.35-0.82-0.830.77
-0.491.00.30.7-0.72-0.86-0.36-0.991.00.49-0.86-0.52-0.670.74-0.490.741.0-0.71-0.281.0-1.00.71-0.821.0-0.29
-0.491.00.30.69-0.73-0.86-0.36-0.991.00.49-0.86-0.53-0.670.74-0.490.731.0-0.71-0.281.0-1.00.71-0.831.0-0.3
-0.18-0.280.080.010.00.01-0.110.29-0.280.180.020.90.83-0.38-0.18-0.1-0.290.50.95-0.290.30.250.77-0.29-0.3
Click cells to compare fundamentals

Equillium Account Relationship Matchups

Equillium fundamentals Accounts

202020212022202320242025 (projected)
Ptb Ratio1.561.631.121.111.01.05
Book Value Per Share3.432.310.950.650.750.71
Free Cash Flow Yield(0.23)(0.3)(0.25)(0.87)(1.0)(0.95)
Operating Cash Flow Per Share(1.21)(1.11)(0.26)(0.63)(0.72)(0.76)
Capex To Depreciation4.490.792.360.40.460.43
Pb Ratio1.561.631.121.111.01.05
Free Cash Flow Per Share(1.22)(1.12)(0.27)(0.63)(0.72)(0.76)
Roic(0.37)(0.48)(2.02)(0.65)(0.75)(0.78)
Net Income Per Share(1.46)(1.35)(3.19)(0.38)(0.44)(0.46)
Payables Turnover0.01630.05880.02970.02680.02410.0171
Cash Per Share4.042.82.111.181.351.29
Pocfratio(4.42)(3.39)(4.09)(1.15)(1.04)(1.09)
Interest Coverage(26.89)(35.22)(58.95)(29.58)(34.01)(35.71)
Capex To Operating Cash Flow(0.008203)(0.001777)(0.0319)(0.002295)(0.00264)(0.002772)
Pfcf Ratio(4.39)(3.38)(3.97)(1.15)(1.03)(1.09)
Days Payables Outstanding22.4K6.2K12.3K13.6K15.7K14.9K
Income Quality0.830.820.141.631.471.54
Roe(0.61)(0.43)(0.59)(3.37)(0.68)(0.71)
Ev To Operating Cash Flow(2.41)(3.78)(2.13)1.51(0.12)(0.11)
Pe Ratio(3.66)(2.79)(0.33)(1.88)(1.69)(1.78)
Return On Tangible Assets(0.2)(0.46)(0.35)(1.37)(0.26)(0.3)
Ev To Free Cash Flow(2.4)(3.75)(2.12)1.46(0.12)(0.11)
Earnings Yield(0.27)(0.36)(3.01)(0.53)(0.61)(0.64)
Net Debt To E B I T D A0.551.070.81.841.661.74
Current Ratio11.799.42.411.792.061.96
Tangible Book Value Per Share3.432.310.950.650.750.71
Shareholders Equity Per Share3.432.310.950.650.750.71
Debt To Equity0.120.150.320.03650.03290.0345
Capex Per Share0.0099240.0019790.0082720.001440.0012960.001231
Graham Net Net3.272.150.790.510.580.55
Interest Debt Per Share0.460.380.330.03790.04350.0414
Debt To Assets0.09690.120.130.01630.01880.0178
Enterprise Value Over E B I T D A(3.25)(1.8)0.22(0.22)(0.2)(0.21)
Price Earnings Ratio(3.66)(2.79)(0.33)(1.88)(1.69)(1.78)
Price Book Value Ratio1.561.631.121.111.01.05
Price Earnings To Growth Ratio5.380.37(0.002435)0.02140.02460.0234
Days Of Payables Outstanding22.4K6.2K12.3K13.6K15.7K14.9K
Price To Operating Cash Flows Ratio(4.42)(3.39)(4.09)(1.15)(1.04)(1.09)
Price To Free Cash Flows Ratio(4.39)(3.38)(3.97)(1.15)(1.03)(1.09)

Pair Trading with Equillium

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Equillium position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will appreciate offsetting losses from the drop in the long position's value.

Moving against Equillium Stock

  0.47CRNX Crinetics PharmaceuticalsPairCorr
  0.46MOLN Molecular PartnersPairCorr
  0.43EYEN EyenoviaPairCorr
  0.41CLDX Celldex TherapeuticsPairCorr
The ability to find closely correlated positions to Equillium could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Equillium when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Equillium - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Equillium to buy it.
The correlation of Equillium is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Equillium moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Equillium moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Equillium can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Equillium Stock Analysis

When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.